Madagascar vs Yemen: Access to anti-retroviral drugs, male
Madagascar
22.0%
in 2024
Yemen
27.0%
in 2024
Madagascar rank
139th
Yemen rank
136th
Access to anti-retroviral drugs, male over time
- Madagascar
- Yemen
How they compare
Yemen currently reports 27.0% against 22.0% in Madagascar, a difference of 5.0%.
That makes Yemen's figure about 1.2 times Madagascar's.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Yemen ahead.
Madagascar ranks 139th and Yemen ranks 136th of 141 countries.
Yemen has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Madagascar | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.4% | 0.8% | 0.4% | Yemen |
| 2010s | 3.4% | 12.7% | 9.3% | Yemen |
| 2020s | 15.0% | 24.0% | 9.0% | Yemen |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Madagascar or Yemen?
- Yemen, at 27.0% against 22.0% in Madagascar as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Madagascar and Yemen?
- 5.0%, with Yemen ahead.
- How many years of comparable data are there for Madagascar and Yemen?
- 25 years are reported by both, from 2000 to 2024.
- How do Madagascar and Yemen rank globally for access to anti-retroviral drugs, male?
- Madagascar ranks 139th and Yemen ranks 136th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.